HIV pre-exposure prophylaxis (PrEP)

PrEP is a highly effective strategy that involves an HIV-negative person taking HIV medications on an ongoing basis to reduce the risk of HIV infection. When PrEP is taken as prescribed, HIV transmission is very rare.

Resources

Filter By

Filter By

Guideline or manual

Preexposure prophylaxis for the prevention of HIV infection in the United States – 2021 update: Clinical providers supplement

Long-term use medications and TDF/FTC PrEP

Research summary

Emergency department HIV pre-exposure prophylaxis (PrEP) referral program

Research summary

CATIE News 07062021

Researchers find HIV PrEP use less than optimal among men in three large Canadian cities

Research summary

Best practices of same-day HIV pre-exposure prophylaxis (PrEP) initiation

Research summary

CATIE News 03092021

Australian researchers study syphilis in men who use HIV pre-exposure prophylaxis (PrEP)

Research summary

CATIE News 03042021

Study underscores need for HPV screening and vaccination in gay and bisexual PrEP users

Guideline or manual

Alberta HIV pre-exposure prophylaxis (PrEP) guidelines

Take PrEP on-demand

Research summary

microscope

Screening alcohol and substance use may ultimately help improve PrEP adherence

Research summary

Injectable cabotegravir highly successful at preventing HIV infection in women

Guideline or manual

Guidance for the use of Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV acquisition in British Columbia